Real-time enrollment status for this chronic myelogenous leukemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:07 PM UTC
| NCT Number | NCT06088888 |
| Recruiting Status | Recruiting |
| Condition | Chronic Myelogenous Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Shenzhen TargetRx Co., Ltd. |
| Last Updated on CT.gov | February 21, 2025 (Feb 21, 2025) |
As of July 13, 2026: Clinical trial NCT06088888 is currently recruiting participants. This clinical trial study for chronic myelogenous leukemia is actively seeking new participants at 2 locations across the United States. The study is sponsored by Shenzhen TargetRx Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06088888 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06088888 was last updated Feb 21, 2025 (February 21, 2025). HelloStudys verifies this status automatically.